Jieli Li
Impact in
-
- Cardiac Fibrosis and Remodeling
- Cardiomyopathy and Myosin Studies
- Pharmacology top 5%
- Fungal Biology and Applications
- Flavonoids in Medical Research
Papers in
-
- Cardiac Fibrosis and Remodeling 7
- Cardiomyopathy and Myosin Studies 4
- Physiology 11
- Clinical Laboratory Practices and Quality Control 10
- Co-authors
- Brenda Russell (9 shared papers)Guang Liang (5 shared papers)Jianchang Qian (2 shared papers)Yuanyuan Qian (2 shared papers)Yiyi Jin (2 shared papers)Wu Luo (2 shared papers)Weiwei Zhu (2 shared papers)Qing H. Meng (9 shared papers)
- Journals
- Clinica Chimica Acta (3 papers)Developmental Biology (2 papers)Clinical Biochemistry (2 papers)The FASEB Journal (2 papers)Journal of Clinical Medicine (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Jieli Li
56 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 96
- Cardiology and Cardiovascular Medicine 300
- Pharmacology 138
- Endocrinology, Diabetes and Metabolism 129
- Cell Biology 93
- Molecular Medicine 41
Countries citing papers authored by Jieli Li
This map shows the geographic impact of Jieli Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieli Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieli Li more than expected).
Fields of papers citing papers by Jieli Li
This network shows the impact of papers produced by Jieli Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieli Li. The network helps show where Jieli Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jieli Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 219 | |
| 2 | 2011 | 108 | |
| 3 | 2018 | 90 | |
| 4 | 2017 | 86 | |
| 5 | 2017 | 78 | |
| 6 | 2011 | 71 | |
| 7 | 2018 | 54 | |
| 8 | 2017 | 52 | |
| 9 | 2013 | 45 | |
| 10 | 2013 | 44 | |
| 11 | 2018 | 44 | |
| 12 | 2011 | 38 | |
| 13 | 2016 | 38 | |
| 14 | 2020 | 31 | |
| 15 | 2019 | 30 | |
| 16 | 2014 | 29 | |
| 17 | 2016 | 29 | |
| 18 | 2013 | 28 | |
| 19 | 2013 | 27 | |
| 20 | 2022 | 27 |
About Jieli Li
Jieli Li is a scholar working on Cardiology and Cardiovascular Medicine, Physiology, Endocrinology, Diabetes and Metabolism, Cell Biology and Molecular Biology, having authored 61 papers that have together received 1.4k indexed citations. Recurring topics across this work include Clinical Laboratory Practices and Quality Control (10 papers), Cardiac Fibrosis and Remodeling (7 papers), Cellular Mechanics and Interactions (6 papers), Congenital heart defects research (5 papers), Cardiomyopathy and Myosin Studies (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Natural Antidiabetic Agents Studies (3 papers) and Curcumin's Biomedical Applications (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (300 citations), Pharmacology (138 citations), Endocrinology, Diabetes and Metabolism (129 citations), Cell Biology (93 citations) and Molecular Medicine (41 citations). Jieli Li has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Brenda Russell, Guang Liang, Jianchang Qian, Yuanyuan Qian, Yiyi Jin, Wu Luo, Weiwei Zhu, Qing H. Meng, Xuzhong Xu and Li Li. Their work appears in journals such as Clinica Chimica Acta, Developmental Biology, Clinical Biochemistry, The FASEB Journal and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.